Dual antiplatelet therapy for mild stroke and transient ischemic attack / 国际脑血管病杂志
International Journal of Cerebrovascular Diseases
; (12): 514-520, 2021.
Article
en Zh
| WPRIM
| ID: wpr-907357
Biblioteca responsable:
WPRO
ABSTRACT
Patients with mild stroke and transient ischemic attack (TIA) have a high risk of early recurrence or deterioration. Antiplatelet therapy has been recognized to reduce the risk of ischemic vascular events. All guidelines recommend antiplatelet therapy for patients with ischemic stroke. Dual antiplatelet therapy (DAPT) refers to the application of two drugs with different mechanisms to block platelet aggregation and prevent thrombosis. There are many combinations of DAPT, and its safety and effectiveness are still uncertain. This article reviews the efficacy and safety of DAPT in patients with mild stroke and TIA.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Guideline
Idioma:
Zh
Revista:
International Journal of Cerebrovascular Diseases
Año:
2021
Tipo del documento:
Article